• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗 RAGE 抗体给药在挤压伤大鼠模型中的治疗效果。

Therapeutic Effectiveness of Anti-RAGE Antibody Administration in a Rat Model of Crush Injury.

机构信息

Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, 2-15 Yamadaoka Suita, Osaka, 565-0871, Japan.

Laboratory of Nano-Bio Probes, RIKEN Quantitative Biology Center, 6-2-3 Furuedai, Suita, Osaka, 565-0874, Japan.

出版信息

Sci Rep. 2017 Sep 25;7(1):12255. doi: 10.1038/s41598-017-12065-4.

DOI:10.1038/s41598-017-12065-4
PMID:28947744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5613014/
Abstract

Crush injury patients often have systemic inflammatory response syndrome that leads to multiple organ failure. Receptor for advanced glycation endproducts (RAGE) functions as a pattern recognition receptor that regulates inflammation. We evaluated the effects of anti-RAGE antibody in a crush injury model. Pressure was applied to both hindlimbs of rats for 6 h by 3.0-kg blocks and then released. Animals were randomly divided into the sham (RAGE-Sh) group, crush (RAGE-Ctrl) group or anti-RAGE antibody-treated crush (RAGE-Tx) group. Samples were collected at 3, 6 and 24 h after releasing pressure. In the RAGE-Ctrl group, fluorescent immunostaining in the lung showed upregulated RAGE expression at 3 h. The serum soluble RAGE (sRAGE) level, which reflects the amount of RAGE expression in systemic tissue, increased at 6 h. Serum interleukin 6 (IL-6; systemic inflammation marker) increased immediately at 3 h. Histological analysis revealed lung injury at 6 and 24 h. Administration of anti-RAGE antibody before releasing compression inhibited upregulated RAGE expression in the lung alveoli, suppressed RAGE-associated mediators sRAGE and IL6, attenuated the lung damage and improved the 7-day survival rate. Collectively, our results indicated that the use of anti-RAGE antibody before releasing compression is associated with a favourable prognosis following crush injury.

摘要

挤压伤患者常伴有全身炎症反应综合征,进而导致多器官功能衰竭。晚期糖基化终产物受体(RAGE)作为一种模式识别受体,可调节炎症反应。我们评估了抗 RAGE 抗体在挤压伤模型中的作用。通过 3.0kg 的砝码对大鼠双侧后肢施加压力 6 小时,然后释放。动物随机分为假手术(RAGE-Sh)组、挤压(RAGE-Ctrl)组或抗 RAGE 抗体治疗挤压伤(RAGE-Tx)组。在释放压力后 3、6 和 24 小时采集样本。在 RAGE-Ctrl 组,肺部荧光免疫染色显示 3 小时时 RAGE 表达上调。血清可溶性 RAGE(sRAGE)水平,反映全身组织中 RAGE 的表达量,在 6 小时时增加。血清白细胞介素 6(IL-6;全身性炎症标志物)在 3 小时时立即增加。组织学分析显示在 6 和 24 小时时肺部损伤。在释放压迫前给予抗 RAGE 抗体可抑制肺肺泡中 RAGE 的上调表达,抑制 RAGE 相关介质 sRAGE 和 IL6,减轻肺损伤并提高 7 天的存活率。总之,我们的研究结果表明,在释放压迫前使用抗 RAGE 抗体与挤压伤后有利的预后相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a647/5613014/012a400a8b70/41598_2017_12065_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a647/5613014/3a0417bc925f/41598_2017_12065_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a647/5613014/327a4984bc82/41598_2017_12065_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a647/5613014/9933f557225a/41598_2017_12065_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a647/5613014/513d4c6383a8/41598_2017_12065_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a647/5613014/f3fc35af55a0/41598_2017_12065_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a647/5613014/012a400a8b70/41598_2017_12065_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a647/5613014/3a0417bc925f/41598_2017_12065_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a647/5613014/327a4984bc82/41598_2017_12065_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a647/5613014/9933f557225a/41598_2017_12065_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a647/5613014/513d4c6383a8/41598_2017_12065_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a647/5613014/f3fc35af55a0/41598_2017_12065_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a647/5613014/012a400a8b70/41598_2017_12065_Fig6_HTML.jpg

相似文献

1
Therapeutic Effectiveness of Anti-RAGE Antibody Administration in a Rat Model of Crush Injury.抗 RAGE 抗体给药在挤压伤大鼠模型中的治疗效果。
Sci Rep. 2017 Sep 25;7(1):12255. doi: 10.1038/s41598-017-12065-4.
2
Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury.高迁移率族蛋白 B1 蛋白的系统参与及抗高迁移率族蛋白 B1 蛋白抗体在挤压伤大鼠模型中的治疗效果。
Shock. 2012 Jun;37(6):634-8. doi: 10.1097/SHK.0b013e31824ed6b7.
3
Anti-high-mobility group box-1 (HMGB1) mediates the apoptosis of alveolar epithelial cells (AEC) by receptor of advanced glycation end-products (RAGE)/c-Jun N-terminal kinase (JNK) pathway in the rats of crush injuries.高迁移率族蛋白 B1(HMGB1)通过受体晚期糖基化终产物(RAGE)/c-Jun N-末端激酶(JNK)通路介导挤压伤大鼠肺泡上皮细胞(AEC)凋亡。
J Orthop Surg Res. 2022 Jan 15;17(1):20. doi: 10.1186/s13018-021-02903-7.
4
RAGE inhibition reduces acute lung injury in mice.RAGE 抑制减轻了小鼠的急性肺损伤。
Sci Rep. 2017 Aug 3;7(1):7208. doi: 10.1038/s41598-017-07638-2.
5
Anti-RAGE antibody attenuates isoflurane-induced cognitive dysfunction in aged rats.抗晚期糖基化终末产物受体抗体可减轻异氟烷诱导的老年大鼠认知功能障碍。
Behav Brain Res. 2017 Mar 30;322(Pt A):167-176. doi: 10.1016/j.bbr.2017.01.012. Epub 2017 Jan 20.
6
Upregulation of Matrix Metalloproteinase-9 Protects against Sepsis-Induced Acute Lung Injury via Promoting the Release of Soluble Receptor for Advanced Glycation End Products.基质金属蛋白酶-9 的上调通过促进晚期糖基化终产物可溶性受体的释放来保护脓毒症诱导的急性肺损伤。
Oxid Med Cell Longev. 2021 Feb 10;2021:8889313. doi: 10.1155/2021/8889313. eCollection 2021.
7
Anti-RAGE antibody selectively blocks acute systemic inflammatory responses to LPS in serum, liver, CSF and striatum.抗 RAGE 抗体可选择性阻断 LPS 在血清、肝脏、CSF 和纹状体中的急性全身炎症反应。
Brain Behav Immun. 2017 May;62:124-136. doi: 10.1016/j.bbi.2017.01.008. Epub 2017 Jan 11.
8
The Beneficial Effects of ETS-GS, a Novel Vitamin E Derivative, on a Rat Model of Crush Injury.新型维生素E衍生物ETS-GS对挤压伤大鼠模型的有益作用
Shock. 2016 Dec;46(6):681-687. doi: 10.1097/SHK.0000000000000681.
9
[Effect of treatment with anti-receptor for advanced glycation end products antibody on multiple organ dysfunction and mortality in rats after severe thermal injury].[晚期糖基化终末产物抗体抗受体治疗对严重热损伤大鼠多器官功能障碍及死亡率的影响]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 Sep;20(9):523-6.
10
Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury.可溶性晚期糖基化终末产物受体在内毒素诱导的肺损伤中的作用
Am J Respir Crit Care Med. 2008 Aug 15;178(4):356-62. doi: 10.1164/rccm.200707-1069OC. Epub 2008 Jun 5.

引用本文的文献

1
Crush injury and crush syndrome: a comprehensive review.挤压伤和挤压综合征:综述
EFORT Open Rev. 2025 Jun 2;10(6):424-430. doi: 10.1530/EOR-2025-0055.
2
Rescue RM/CS-AKI by blocking strategy with one-dose anti-myoglobin RabMAb.通过单剂量抗肌红蛋白兔单克隆抗体阻断策略挽救肾损伤分子-1/胱抑素C急性肾损伤
Nat Commun. 2025 Jan 26;16(1):1044. doi: 10.1038/s41467-025-56353-4.
3
Tissue-resident macrophages exacerbate lung injury after remote sterile damage.组织驻留巨噬细胞会加剧远程无菌损伤后的肺损伤。

本文引用的文献

1
RAGE-TLR Crosstalk Sustains Chronic Inflammation in Neurodegeneration.RAGE-TLR 相互作用在神经退行性变中的慢性炎症中持续存在。
Mol Neurobiol. 2018 Feb;55(2):1463-1476. doi: 10.1007/s12035-017-0419-4. Epub 2017 Feb 6.
2
Cleaved but not endogenous secretory RAGE is associated with outcome in acute ischemic stroke.裂解而非内源性分泌的 RAGE 与急性缺血性脑卒中的结局相关。
Neurology. 2016 Jan 19;86(3):270-6. doi: 10.1212/WNL.0000000000002287. Epub 2015 Dec 18.
3
Advanced glycation end products accelerate arteriosclerosis after renal transplantation through the AGE/RAGE/ILK pathway.
Cell Mol Immunol. 2024 Apr;21(4):332-348. doi: 10.1038/s41423-024-01125-1. Epub 2024 Jan 17.
4
RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer.晚期糖基化终末产物受体抑制剂TTP488(阿泽利酮)可抑制三阴性乳腺癌的转移。
NPJ Breast Cancer. 2023 Jul 13;9(1):59. doi: 10.1038/s41523-023-00564-9.
5
Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives.靶向 RAGE 以预防 SARS-CoV-2 介导的多器官衰竭:假说与展望。
Life Sci. 2021 May 1;272:119251. doi: 10.1016/j.lfs.2021.119251. Epub 2021 Feb 23.
6
Emerging medical therapies in crush syndrome - progress report from basic sciences and potential future avenues.挤压综合征中的新兴医学疗法——基础科学的进展报告及潜在的未来方向。
Ren Fail. 2020 Nov;42(1):656-666. doi: 10.1080/0886022X.2020.1792928.
7
β1-Blocker improves survival and ventricular remodelling in rats with lethal crush injury.β1 受体阻滞剂可改善致死性挤压伤大鼠的存活率和心室重构。
Eur J Trauma Emerg Surg. 2022 Feb;48(1):455-470. doi: 10.1007/s00068-020-01408-y. Epub 2020 Jun 2.
8
Surfen-mediated blockade of extratumoral chondroitin sulfate glycosaminoglycans inhibits glioblastoma invasion. Surf 介导的细胞外软骨素硫酸糖胺聚糖阻断抑制脑胶质母细胞瘤侵袭。
FASEB J. 2019 Nov;33(11):11973-11992. doi: 10.1096/fj.201802610RR. Epub 2019 Aug 9.
晚期糖基化终末产物通过AGE/RAGE/ILK途径加速肾移植后的动脉硬化。
Exp Mol Pathol. 2015 Oct;99(2):312-9. doi: 10.1016/j.yexmp.2015.07.009. Epub 2015 Jul 23.
4
The clinical significance of circulating soluble RAGE in patients with severe sepsis.严重脓毒症患者循环中可溶性晚期糖基化终末产物受体的临床意义
J Trauma Acute Care Surg. 2015 Jun;78(6):1086-93; discussion 1093-4. doi: 10.1097/TA.0000000000000651.
5
sRAGE in septic shock: a potential biomarker of mortality.脓毒性休克中的可溶性晚期糖基化终末产物受体:一种潜在的死亡生物标志物。
Rev Bras Ter Intensiva. 2014 Oct-Dec;26(4):392-6. doi: 10.5935/0103-507X.20140060.
6
Investigation of phosphoproteome in RAGE signaling.RAGE信号通路中磷酸化蛋白质组的研究。
Proteomics. 2015 Jan;15(2-3):245-59. doi: 10.1002/pmic.201400169. Epub 2014 Dec 17.
7
Plasmatic isoforms of cytokeratin 18 and RAGE after severe trauma: a longitudinal cohort study.严重创伤后细胞角蛋白18和晚期糖基化终末产物受体的血浆异构体:一项纵向队列研究。
J Trauma Acute Care Surg. 2014 Oct;77(4):577-84. doi: 10.1097/TA.0000000000000376.
8
Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress.TAK-242,一种 Toll 样受体 4 抑制剂,可降低应激后大鼠大脑额叶皮质的神经炎症。
J Neuroinflammation. 2014 Jan 11;11:8. doi: 10.1186/1742-2094-11-8.
9
Crush syndrome: a case report and review of the literature.挤压综合征:一例病例报告及文献综述
J Emerg Med. 2014 Feb;46(2):313-9. doi: 10.1016/j.jemermed.2013.08.052. Epub 2013 Nov 5.
10
RAGE and TLRs: relatives, friends or neighbours?RAGE 和 TLRs:亲戚、朋友还是邻居?
Mol Immunol. 2013 Dec;56(4):739-44. doi: 10.1016/j.molimm.2013.07.008. Epub 2013 Aug 14.